Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.
Ressources
Commentary | 2023
Legal system/law enforcement, Harm reduction, Advocacy
Report | 2023
Evidence base, About PWUD, Safer supply, Wrap-around services, Outcomes, Housing, Transitions in care/treatment, Stimulants, Injecting drugs
To characterize polysubstance death in the United States during the transition to the fourth wave of the drug overdose crisis.
Original research | 2023
Overdose, Mortality, Equity, Stimulants, About PWUD
The aim of this study was to assess the effect of the ‘How to save a life’ (HTSAL) mass media campaign on the supply of take-home naloxone (THN).
Original research | 2023
Harm reduction, Outcomes
Inpatient guidelines for methadone titration do not exist, whereas outpatient guidelines lack flexibility and do not consider individual opioid tolerance.
Original research | 2023
Hospitals, Substitution/OAT, Transitions in care/treatment, Clinical guidance, About prescribers, Outcomes
Despite the support and mentoring, only sparse information is available about how drug quality, drug prices and user expectations match at these locations.
Original research | 2023
Drug checking
Our objective was to describe pre-pandemic trends and how they changed with the onset of COVID-19 and thereafter.
Original research | 2023
Hospitals, Overdose
This article reviews research investigating the synergistic interaction of opioid-related morbidity and mortality with other social, psychiatric, and biological conditions, to describe how and why
Scoping review | 2023
Equity, Overdose
Despite extensive evidence regarding the negative effects of stigma experienced by people living with HIV (PLHIV) and people who inject drugs within health care settings, comparatively little evide
Original research | 2023
Stigma, Hospitals, About prescribers, Workplace
The purpose of this study is to explore barriers and facilitators to engagement in drug treatment among people who inject drugs (PWID) residing in a rural county in West Virginia.
Original research | 2023
About PWUD, Barriers and enablers, Transitions in care/treatment
Video | 2023
Harm reduction, Safer supply, Peer/PWLLE program involvement, Wrap-around services
Pharmacy administration and dispensing of methadone treatment for opioid use disorder (PADMOUD) may address inadequate capability of opioid treatment programs (OTPs) in the US by expanding access t
Original research | 2023
About pharmacists, About PWUD, Substitution/OAT
Commentary | 2023
Safer supply, Stimulants, About prescribers, Policy/Regulatory, Clinical guidance
We sought to examine the care experiences of patients with opioid use disorder (OUD) receiving medication-based treatment (MOUD) in a primary care
Original research | 2023
About PWUD, Wrap-around services
This study evaluates the presence of stigmatizing language (SL) in clinical notes and detects patient- and provider-level differences.
Original research | 2023
About prescribers, Stigma, Equity
Case study | 2022
Withdrawal, Clinical guidance, Hospitals
Case study | 2023
Withdrawal, Hallucinogens/psychedelics, Clinical guidance
We investigated whether participation in an addiction medicine clinic with active case management led to improvements in patients' re
Original research | 2023
Stimulants, Transitions in care/treatment, Legal system/law enforcement, Crime, About PWUD
Commentary | 2023
Substitution/OAT
